Scope and Contents From the Series: Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...

Scope and Contents From the Series: Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...

Scope and Contents From the Series: Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...

Scope and Contents From the Series: Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...

Scope and Contents From the Series: Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...

Scope and Contents From the Series: Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...

Scope and Contents From the Series: Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...

Scope and Contents From the Series: Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...

Scope and Contents From the Series: Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...